Allergy Therapeutics plc (LON:AGY – Get Free Report)’s share price traded down 11.6% during trading on Friday . The company traded as low as GBX 5.20 ($0.07) and last traded at GBX 5.20 ($0.07). 687,506 shares traded hands during mid-day trading, a decline of 1% from the average session volume of 695,294 shares. The stock had previously closed at GBX 5.88 ($0.08).
Allergy Therapeutics Price Performance
The firm has a market capitalization of £267.84 million, a P/E ratio of -86.67, a PEG ratio of -30.70 and a beta of 1.40. The company has a fifty day moving average of GBX 5.05 and a 200 day moving average of GBX 4.84. The company has a debt-to-equity ratio of 37.22, a current ratio of 1.40 and a quick ratio of 1.48.
Allergy Therapeutics Company Profile
Allergy Therapeutics plc, a commercial biotechnology company, engages in the research and development of allergy treatments. The company sells injectable and sublingual allergen-specific immunotherapies; and offers prescription for the treatment of pollen-related allergies particularly to grasses, weeds, and trees, as well as diagnostics.
Recommended Stories
- Five stocks we like better than Allergy Therapeutics
- The Most Important Warren Buffett Stock for Investors: His Own
- NVIDIA’s Blackwell Chips Set for Arizona Manufacturing by TSMC?
- What Are Dividends? Buy the Best Dividend Stocks
- Okta: Bullish Signals Suggest a Market Reversal Is Underway
- How to Know Which Cryptocurrency to Buy: A Guide for Investors
- BlackRock Makes Waves With $12B Private Credit Acquisition
Receive News & Ratings for Allergy Therapeutics Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Allergy Therapeutics and related companies with MarketBeat.com's FREE daily email newsletter.
